Discussão: Patentes farmacêuticas e acesso a medicamentos

Em “Between pharmaceutical patents and European patients: is a compromise still possible?”, Livio Garattini e Ana Padula recomendam alterações no atual sistema de proteção de propriedade intelectual europeu: The main radical change should concern the present management of pharmaceutical patents by introducing a specific agency dedicated to them. Secondly, specific pharmaceutical patents could be restricted […]